T&R Biofab Co., Ltd. (KOSDAQ:246710)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,020.00
-25.00 (-1.22%)
Jun 10, 2026, 3:30 PM KST
Market Cap96.28B -4.9%
Revenue (ttm)29.73B +208.4%
Net Income-31.21B
EPS-811.88
Shares Out 47.66M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume141,112
Open2,030.00
Previous Close2,045.00
Day's Range2,000.00 - 2,100.00
52-Week Range1,127.00 - 4,925.00
Beta0.45
Analystsn/a
Price Targetn/a
Earnings DateAug 25, 2026

About T&R Biofab

T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 246710
Full Company Profile

Financial Performance

In 2025, T&R Biofab's revenue was 26.97 billion, an increase of 453.32% compared to the previous year's 4.87 billion. Losses were -34.94 billion, 355.1% more than in 2024.

Financial Statements